Edwards Lifesciences Executive and Leadership Team

Linda Henderson, the Vice President, Chief of Staff To the Chief Executive Officer at Edwards Lifesciences, manages executive workflows and facilitates strategic communication across the leadership team. Henderson coordinates high-level initiatives that align internal operations with the broader mission of developing structural heart disease solutions. By streamlining decision-making processes, the Vice President, Chief of Staff To the Chief Executive Officer ensures that organizational priorities remain focused on clinical research and patient outcomes. This role involves constant collaboration with the Board and senior management to maintain operational excellence. Linda Henderson drives efficiency by optimizing the flow of information between departments, which supports the company's ability to deliver life-changing therapies. Through rigorous oversight of executive projects, the Vice President, Chief of Staff To the Chief Executive Officer maintains the structural integrity of the corporate strategy, ultimately fostering a culture of accountability and precision in every medical technology advancement.

Gerianne Sarte, the Senior Vice President, Business Unit Chief Financial Officer - Surgical at Edwards Lifesciences, directs the financial planning and analysis for the surgical business unit. Sarte oversees capital allocation and budgetary discipline to support the development of advanced heart valve technologies. By monitoring fiscal performance, the Senior Vice President, Business Unit Chief Financial Officer - Surgical ensures that resources remain dedicated to high-impact clinical research and product innovation. This leadership position requires close coordination with operational teams to maximize profitability while maintaining the highest standards of medical device quality. Gerianne Sarte evaluates market trends to guide long-term investment strategies, which directly influences the company's competitive position in the cardiovascular sector. Through precise financial modeling and risk management, the Senior Vice President, Business Unit Chief Financial Officer - Surgical secures the necessary funding to expand surgical product reach, thereby strengthening the overall financial health of the organization.

Miyuki Ogushi, the Representative Executive Officer and President and at Edwards Lifesciences, directs regional operations and oversees the implementation of corporate policies within specific international markets. Ogushi manages local stakeholder relationships and ensures that the company's mission of improving patient outcomes remains consistent across diverse healthcare environments. By coordinating with global leadership, the Representative Executive Officer and President and aligns regional activities with the overarching strategy for structural heart disease management. This role involves navigating complex regulatory frameworks and fostering close collaboration with local healthcare professionals to drive the adoption of advanced medical technologies. Miyuki Ogushi monitors operational performance to ensure that regional goals support the company's global growth objectives. Through effective leadership and market-specific insights, the Representative Executive Officer and President and strengthens the company's presence, ensuring that life-changing therapies are accessible to patients in key geographic regions while maintaining the highest standards of quality and clinical efficacy.

Geoffrey Crowley, the President at Edwards Lifesciences, executes the daily operational strategy and ensures that all business units function in alignment with the corporate mission. Crowley oversees the integration of clinical research findings into commercial product lines, which enhances the company's ability to address serious cardiovascular conditions. By managing cross-functional teams, the President drives the development of innovative solutions for structural heart disease and critical care monitoring. This leadership role requires constant interaction with department heads to optimize performance and maintain high standards of patient care. Geoffrey Crowley evaluates operational metrics to identify areas for improvement, ensuring that the company remains agile in a competitive medical technology landscape. Through a focus on operational excellence and strategic execution, the President supports the delivery of life-changing therapies, ultimately ensuring that the organization meets its commitment to healthcare professionals and patients worldwide through advanced technology and clinical research.

Daveen Chopra, the Corporate Vice President, Surgical Structural Heart at Edwards Lifesciences, leads the global development and commercialization of surgical heart valve therapies. Chopra manages the product pipeline, ensuring that new technologies address complex cardiovascular conditions with precision and safety. By overseeing clinical trials and physician partnerships, the Corporate Vice President, Surgical Structural Heart drives the adoption of life-changing surgical solutions across international markets. This role requires deep technical expertise to navigate the regulatory landscape and ensure that every innovation meets the rigorous demands of healthcare professionals. Daveen Chopra coordinates with research teams to refine structural heart components, which enhances patient recovery and long-term health. Through strategic market expansion and a focus on clinical excellence, the Corporate Vice President, Surgical Structural Heart maintains the company's leadership in the surgical space, ensuring that advanced therapies reach patients who require critical intervention for heart valve disease.

Donald Bobo, the Corporate Vice President, Strategy & Corporate Development at Edwards Lifesciences, architects the long-term growth roadmap and identifies strategic acquisition opportunities. Bobo evaluates emerging medical technologies to ensure the company remains at the forefront of structural heart innovation. By leading corporate development initiatives, the Corporate Vice President, Strategy & Corporate Development aligns internal capabilities with external market opportunities to drive sustainable expansion. This role involves frequent engagement with the Board to assess competitive threats and capitalize on new clinical frontiers. Donald Bobo manages the integration of new assets, which broadens the portfolio of critical care monitoring and heart valve solutions. Through rigorous strategic planning, the Corporate Vice President, Strategy & Corporate Development ensures that the organization maintains its focus on high-growth areas, ultimately securing a dominant market position while delivering consistent value through advanced medical technology and collaborative healthcare partnerships.

Joseph Nuzzolese, the Corporate Vice President, Global Supply Chain & Quality at Edwards Lifesciences, manages the end-to-end logistics and manufacturing standards for all medical technologies. Nuzzolese ensures that the global supply chain remains resilient and capable of delivering critical heart valve components to healthcare facilities worldwide. By enforcing rigorous quality control protocols, the Corporate Vice President, Global Supply Chain & Quality guarantees that every product meets the highest safety standards for structural heart disease treatment. This role involves optimizing production processes to increase efficiency and reduce lead times, which directly impacts the company's ability to serve patients in urgent need. Joseph Nuzzolese coordinates with international manufacturing sites to maintain consistent output and regulatory compliance. Through strategic oversight of the supply chain, the Corporate Vice President, Global Supply Chain & Quality supports the company's mission by ensuring that life-changing therapies are manufactured and distributed with absolute precision and reliability.